- Trials with a EudraCT protocol (417)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17)
417 result(s) found for: Liver transplantation.
Displaying page 1 of 21.
EudraCT Number: 2009-015890-11 | Sponsor Protocol Number: AGO/2009/007 | Start Date*: 2009-11-03 | |||||||||||
Sponsor Name:University Hospital Ghent | |||||||||||||
Full Title: Conditioning with volatile anesthetics in liver transplantation | |||||||||||||
Medical condition: Liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021333-31 | Sponsor Protocol Number: TOP2010-LMU | Start Date*: 2011-08-23 | |||||||||||
Sponsor Name:Klinikum der Universität München | |||||||||||||
Full Title: Reduktion des Ischämie-Reperfusionsschadens durch ex-vivo Tacrolimus-Perfusion marginaler Organe vor Lebertransplantation (Tacrolimus-Organ-Perfusion TOP-Studie) | |||||||||||||
Medical condition: Chonical terminal liver insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001361-15 | Sponsor Protocol Number: CAEB071B2101 | Start Date*: 2008-01-28 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: An open-label, two-period, multi-center, single dose study to assess the pharmacokinetics of AEB071 in de novo liver transplant patients | |||||||||||||
Medical condition: liver transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012258-19 | Sponsor Protocol Number: F506-CL-0403 | Start Date*: 2011-03-09 | |||||||||||||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||||||||||||
Full Title: A Multicentre, Open-label, Pharmacokinetic Study of Modigraf® (Tacrolimus granules) in de novo Paediatric Allograft Recipients.Estudio Abierto, Multicéntrico, Farmacocinético de Modigraf® (Tacróli... | |||||||||||||||||||||||
Medical condition: De novo allograft transplantation (liver, heart, kidney) in paediatric patients. Pacientes pediátricos que reciben un trasplante de aloinjerto de novo ( hígado, corazón y riñón) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) GB (Completed) DE (Completed) BE (Completed) FR (Ongoing) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003561-15 | Sponsor Protocol Number: MYSTEP1 | Start Date*: 2016-08-30 | |||||||||||
Sponsor Name:University Hospital of Tuebingen | |||||||||||||
Full Title: Safety and Tolerance of Immunomodulating Therapy with Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation | |||||||||||||
Medical condition: Side effects of life-long immunosuppressive medication account for major morbidity after pediatric liver transplantation and impair quality of life. In-vivo and in-vitro studies have shown that MSC... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000627-26 | Sponsor Protocol Number: FK04 | Start Date*: 2008-09-29 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Conversion from cyclosporine to tacrolimus followed by randomized C0 or Bayesian monitoring using the C4 timepoint The effect on kidney function | |||||||||||||
Medical condition: Effect of immunosuppressive medication on renal function following livertransplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004268-38 | Sponsor Protocol Number: Transplant_ABT-1 | Start Date*: 2014-10-27 | ||||||||||||||||
Sponsor Name:Semmelweis Egyetem Transzplantációs és Sebészeti Klinika | ||||||||||||||||||
Full Title: Individual Patient Access to AbbVie ABT-450/ritopnavir/ABT-267 and ABT-333 Coadministeres with ribavirin (RBV) in Adult Liver Transplant Recipient with Genotype 1 Hepatitis C Virus Infection | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001872-12 | Sponsor Protocol Number: CL-N-LTX-III/08-ESP/19 | Start Date*: 2021-12-28 | |||||||||||||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||||||||||||
Full Title: A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation | |||||||||||||||||||||||
Medical condition: Liver transplantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002231-32 | Sponsor Protocol Number: PMR-EC-1106 | Start Date*: 2009-03-04 | |||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||
Full Title: A MULTICENTER, THREE ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED... | |||||||||||||
Medical condition: RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED POST-TRANSPLANT) AND MMF WITH OR WITHOUT SIMULECT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) AT (Completed) HU (Completed) BE (Completed) CZ (Completed) IE (Completed) DE (Completed) FR (Completed) ES (Completed) GB (Completed) IT (Completed) SE (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022660-12 | Sponsor Protocol Number: PRAISE_ZKS0006 | Start Date*: 2011-02-02 | |||||||||||
Sponsor Name:Friedrich Schiller University | |||||||||||||
Full Title: A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation | |||||||||||||
Medical condition: the early postoperative period after liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002568-18 | Sponsor Protocol Number: 5B | Start Date*: 2015-07-15 |
Sponsor Name:Stockholm County Council, Karolinska University Hospital Huddinge, Department of Anesthesiology and Intensive Care | ||
Full Title: Albumin mass balance and kinetics in liver transplantation. An open exploratory pilot study | ||
Medical condition: liver transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002105-22 | Sponsor Protocol Number: EVL-VHC-HVH.12 | Start Date*: 2012-08-17 | ||||||||||||||||
Sponsor Name:Dra Itxarone Bilbao. Servicio de cirugía hepatobiliopancreatica y trasplantes. HUVH | ||||||||||||||||||
Full Title: Personal monitoring of liver transplant patients infected with Hepatitis C Virus. Pilot study to compare the evolution of Hepatitis C by receiving immunosuppression with tacrolimus in combination w... | ||||||||||||||||||
Medical condition: Recurrence of hepatitis C post-liver transplantation in patients with hepatitic C. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000306-46 | Sponsor Protocol Number: FG-506E-11-03 | Start Date*: 2004-07-16 |
Sponsor Name:FUJISAWA | ||
Full Title: A multicentre, 1:1 randomised, double blind, two arm parallel group study to evaluate and compare the efficacy and safety of modified release tacrolimus FK506E (MR4) versus tacrolimus FK506 in comb... | ||
Medical condition: Liver transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) FI (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004325-91 | Sponsor Protocol Number: CRAD001HIT34 | Start Date*: 2014-01-25 | |||||||||||
Sponsor Name:NOVARTIS FARMA S.p.A | |||||||||||||
Full Title: Multicenter, prospective, open-label, controlled, randomized, parallel groups study to evaluate the renal function of adult liver transplant recipients treated with two everolimus-based immunosuppr... | |||||||||||||
Medical condition: liver transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002510-13 | Sponsor Protocol Number: TROMBOFIBtrial | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Antoni Sabaté Pes (Servicio de Anestesiología y Reanimación) del Hospital Universitari de Bellvitge | |||||||||||||
Full Title: Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial. TROMBOFIB trial | |||||||||||||
Medical condition: Liver transplantation is a special risk situation for acute and severe bleeding determined by the complexity of the surgical procedure and by the alteration of haemostasis and coagulation factors, ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003528-29 | Sponsor Protocol Number: CCHI621ADE04 | Start Date*: 2016-04-14 | ||||||||||||||||
Sponsor Name:Novartis Pharma GmbH | ||||||||||||||||||
Full Title: A Multicenter, Open-label, Randomized, Two Arm Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Cyclosporine/Cyclosporine ... | ||||||||||||||||||
Medical condition: Liver Transplantation Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-007177-20 | Sponsor Protocol Number: Sirolimus_Liver_Tolerance | Start Date*: 2009-09-07 | |||||||||||
Sponsor Name:Hospital Clinic Barcelona | |||||||||||||
Full Title: EFECTO DEL SIROLIMUS SOBRE LOS BIOMARCADORES RELACIONADOS CON LA TOLERANCIA EN RECEPTORES DE TRASPLANTE HEPÁTICO ESTABLES | |||||||||||||
Medical condition: Stable liver transplant recipients identified as non-tolerant (i.e. requiring indefinite immunosuppressive therapy) on the basis of peripheral blood transcriptional biomarkers. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005453-13 | Sponsor Protocol Number: EGRADICATE | Start Date*: 2016-08-03 | ||||||||||||||||
Sponsor Name:Fundació clínic per a la Recerca Biomèdica | ||||||||||||||||||
Full Title: PILOT STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF GRAZOPREVIR + ELBASVIR FOR 12 OR 16 WEEKS IN LIVER TRANSPLANT RECIPIENTS | ||||||||||||||||||
Medical condition: HCV infection and liver trasplant | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-000936-28 | Sponsor Protocol Number: PMR-EC-1105 | Start Date*: 2006-09-14 | |||||||||||
Sponsor Name:Astellas Pharma Europe Limited | |||||||||||||
Full Title: A MULTICENTER, OPEN, SINGLE SEQUENCE CROSSOVER STUDY TO ASSESS THE SAFETY AND EFFICACY OF A TACROLIMUS MODIFIED RELEASE, FK506E (MR4), BASED IMMUNOSUPPRESSIVE REGIMEN IN STABLE LIVER TRANSPLANT PAT... | |||||||||||||
Medical condition: Stable, adult liver transplant recipients (≥ 12 months post transplant) who are currently treated with Prograf. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IE (Completed) ES (Completed) FR (Completed) CZ (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000691-34 | Sponsor Protocol Number: ATG-IRA.HVH.10 | Start Date*: 2011-07-06 | ||||||||||||||||
Sponsor Name:Dra Itxarone Bilbao. Servicio de Cirugía Hepatobiliopancreatica y Trasplantes. HUVH. | ||||||||||||||||||
Full Title: Single-center pilot study, prospective, open-label, to evaluate the efficacy and safety of immunosuppression low nephrotoxicity, based on the use of ATeGe-Fresenius in patients with renal insuffici... | ||||||||||||||||||
Medical condition: Renal failure in liver transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
